Endothelial cell function and thrombosis.
暂无分享,去创建一个
[1] J. Emeis. The Control of tPA and PAI-1 Secretion from the Vessel Wall , 1995 .
[2] J. Pearson,et al. von Willebrand factor is an acute phase reactant in man. , 1989, Thrombosis research.
[3] S. Rapaport,et al. Studies of the Factor Xa-Dependent Inhibitor of Factor VIIa/Tissue Factor (Extrinsic Pathway Inhibitor) from Cell Supernates of Cultured Human Umbilical Vein Endothelial Cells , 1989, Thrombosis and Haemostasis.
[4] D. Wagner. Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.
[5] K. Hajjar. Cellular Receptors in the Regulation of Plasmin Generation , 1995, Thrombosis and Haemostasis.
[6] C. Esmon,et al. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. , 1994, The Journal of biological chemistry.
[7] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[8] A. K. Pedersen,et al. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. , 1984, The New England journal of medicine.
[9] D. Crossman,et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. , 1990, The Journal of biological chemistry.
[10] H. Friedman,et al. Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells , 1990, Cell.
[11] J. Pearson,et al. Vessel wall interactions regulating thrombosis. , 1994, British medical bulletin.
[12] R. Derksen,et al. Synergistic Effect of Low Doses of Tumor Necrosis Factor and Sera from Patients with Systemic Lupus Erythematosus on the Expression of Procoagulant Activity by Cultured Endothelial Cells , 1989, Thrombosis and Haemostasis.
[13] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[14] J. Moake,et al. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. , 1986, Clinics in haematology.
[15] J. Cooke,et al. Arginine Restores Cholinergic Relaxation of Hypercholesterolemic Rabbit Thoracic Aorta , 1991, Circulation.
[16] S. Moncada,et al. Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.
[17] S Moncada,et al. Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Saito,et al. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] H. Niwano,et al. Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von willebrand factor and tissue‐type plasminogen activator , 1992, American journal of hematology.
[20] E. Bjørklid,et al. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets , 1984, British journal of haematology.
[21] A. Marcus,et al. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. , 1991, The Journal of clinical investigation.
[22] T. Carter,et al. Regulation of Prostacyclin Synthesis in Endothelial Cells , 1992 .
[23] D. Fass,et al. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. , 1986, The Journal of clinical investigation.
[24] W. Kisiel,et al. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface , 1992 .
[25] G. Zimmerman,et al. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. , 1985, The Journal of clinical investigation.
[26] F. Siddiqui,et al. Binding of Platelet Agglutinating Protein p 37 from the Plasma of a Patient with Thrombotic Thrombocytopenic Purpura to Human Platelets , 1991, Thrombosis and Haemostasis.
[27] K. Nagai,et al. Inhibitory effects of TTP sera on binding of anti‐platelet glycoprotein IIb‐IIIa monoclonal antibodies to human vascular endothelial cells , 1987, American journal of hematology.
[28] S. Moncada. EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN , 1982, British journal of pharmacology.
[29] K. Amano,et al. Fluctuations in Plasma Levels of Thrombomodulin in Patients with DIC , 1992, Thrombosis and Haemostasis.
[30] G. Remuzzi,et al. Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] T. Ohka,et al. Changes in plasma levels of thrombomodulin during haemodialysis. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[32] E. Nabel,et al. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. , 1990, Journal of the American College of Cardiology.
[33] T. Lyberg,et al. Cellular cooperation in endothelial cell thromboplastin synthesis , 1983, British journal of haematology.
[34] S Moncada,et al. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. , 1987, Biochemical and biophysical research communications.
[35] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[36] P. Mannucci,et al. von Willebrand factor: a marker of endothelial damage? , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[37] J. Marcum,et al. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. , 1984, The Journal of clinical investigation.
[38] T. van der Poll,et al. Fibrinolytic response to tumor necrosis factor in healthy subjects , 1991, The Journal of experimental medicine.
[39] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[40] D. Cines,et al. Antibody and immune complexes induce tissue factor production by human endothelial cells. , 1986, Journal of immunology.
[41] D. Loskutoff. The Biochemistry, Cell and Molecular Biology of Type 1 Plasminogen Activator Inhibitor , 1991 .
[42] J. V. van Mourik,et al. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. , 1990, Journal of immunology.
[43] S. Tannenbaum,et al. Immune endothelial-cell injury in heparin-associated thrombocytopenia. , 1987, The New England journal of medicine.
[44] H. Drexler,et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.
[45] P. Vanhoutte,et al. Flow-induced release of endothelium-derived relaxing factor. , 1986, The American journal of physiology.
[46] G. Zimmerman,et al. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion , 1990, The Journal of cell biology.
[47] J. Kelton,et al. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura , 1990, British journal of haematology.
[48] A. Marcus,et al. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. , 1980, The Journal of clinical investigation.
[49] J. Soria,et al. Effect of Lupus Anticoagulant on Antithrombogenic Properties of Endothelial Cells - Inhibition of Thrombomodulin-Dependent Protein C Activation , 1988, Thrombosis and Haemostasis.
[50] V. Hinsbergh. Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. , 1988, Haemostasis.
[51] J. Pearson. Autoantibodies to Endothelial Cells , 1991 .
[52] D. Moscatelli,et al. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells , 1987, The Journal of cell biology.
[53] S. Rapaport,et al. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. , 1990, Blood.
[54] M. Shuman,et al. Characterization of the effects of cultured vascular cells on the activation of blood coagulation. , 1983, Blood.
[55] R. Derksen,et al. 8 Antiphospholipid antibodies: Specificity and pathophysiology , 1993 .
[56] H. Gerlach,et al. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. , 1990, The Journal of clinical investigation.
[57] M. Gimbrone,et al. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. , 1988, The Journal of biological chemistry.
[58] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[59] W. Williams,et al. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. , 1987, Circulation.
[60] C. Dollery,et al. Prostacyclin is not a circulating hormone in man. , 1982, Prostaglandins.
[61] D. Crossman,et al. Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. , 1990, Blood.
[62] G. Roth,et al. Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. , 1991, Blood.
[63] C. Esmon. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] T. Rink,et al. Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? , 1987, Nature.
[65] J. Paramo,et al. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. , 1985, The Journal of clinical investigation.
[66] J. Pearson. The control of production and release of haemostatic factors in the endothelial cell. , 1993, Bailliere's clinical haematology.
[67] M. Stemerman,et al. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts , 1977 .
[68] M J Davies,et al. A macro and micro view of coronary vascular insult in ischemic heart disease. , 1990, Circulation.
[69] J. Pearson,et al. Nucleotide metabolism by endothelium. , 1985, Annual review of physiology.
[70] R. Cotran,et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.
[71] J. Pearson,et al. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti‐endothelial cell antibodies and their relation to anti‐neutrophil cytoplasm antibodies , 1991, Clinical and experimental immunology.
[72] P. Woo,et al. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. , 1988, Clinical and experimental immunology.
[73] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[74] Tatsuya Hayashi,et al. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation , 1992, American journal of hematology.
[75] J. Pearson,et al. Stimulation of prostaglandin production through purinoceptors on cultured porcine endothelial cells. , 1983, The Biochemical journal.
[76] G. Schernthaner,et al. The effect of near-normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients. , 1989, The Journal of clinical endocrinology and metabolism.
[77] P. Sandset,et al. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin. , 1991, Haemostasis.